Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Knowbe4, Inc. (KNBE)
Zymergen Inc. (ZY)
Neuropace Inc (NPCE)
Upcoming IPO
Agiliti, Inc (AGTI)
Treace Medical Concepts, Inc. (TMCI)
Latham Group, Inc. (SWIM)
Rain Therapeutics Inc. (RAIN)
Impel Neuropharma, Inc. (IMPL)
Ftc Solar, Inc. (FTCI)
Aveanna Healthcare Holdings Inc. (AVAH)
Endeavor Group Holdings (EDR)
The Fortegra Group, Inc. (FRF)
Privia Health Group, Inc. (PRVA)
Priced IPO
Uipath Inc (PATH)
Doubleverify Holdings, Inc. (DV)
Skywater Technology, Inc. (SKYT)
Infobird (IFBD)
Troika Media Group, Inc. (TRKA)
Biomea Fusion, Inc. (BMEA)
Akoya Biosciences, Inc. (AKYA)
Recursion Pharmaceuticals, Inc. (RXRX)
Karat Packaging Inc. (KRT)
AppLovin (APP)
Esports Technologies (EBET)
Agilon Health, Inc. (AGL)
TuSimple Holdings Inc (TSP)
Coinbase Global, Inc. (COIN)
Alkami Technology, Inc. (ALKT)
Reneo Pharmaceuticals, Inc. (RPHM)
Vectivbio Holding Ag (VECT)
UTime Limited (UTME)
Frontier Group Holdings (ULCC)
Compass, Inc. (COMP)
More companies

Research Alliance II (RACB)

Sector - SPAC

Price chart

+3.4%
Return from IPO

Last SPACs News

IPO Profile

About company

They are a newly organized blank check company. While they may pursue an acquisition opportunity in any business, industry, sector or geographical location, they intend to focus on industries that complement their management team’s background, and to capitalize on the ability of their management team to identify and acquire a business, focusing on the healthcare industry, with an emphasis on the biotechnology sector where their management has extensive investment experience. Their sponsor is an affiliate of RA Capital, a leading life sciences focused investment firm with over $7 billion of regulatory assets under management as of December 31, 2020. Since its launch in 2002, RA Capital has focused exclusively on the healthcare industry. Peter Kolchinsky, PhD, their founding Chairman and Chief Executive Officer, founded RA Capital, where he is a Managing Partner. Matthew Hammond, PhD, their founding Chief Investment Officer and Director and Tess Cameron, their founding Chief Financial Officer and Director, are Principals on the investment team at RA Capital.
Industry
Blank Checks
CEO CFO
-
Employees Founded
3 2020

Contacts

Address: 3172 North Rainbow Blvd. #1278 Las Vegas, Nv 89108

Telephone: (617) 778.2500

Web page: http://www.racap.com

IPO information

First Trade Date 3/18/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 13
Shares Revised (MM) 13
Expected offer amount (MM) $130
Realized offer amount(MM) $130

Financial Data (last reporting year)

Market Cap (MM) $167.5
Revenues (MM) $0
Net Income (Loss) (MM) $0

Voting

What do you think will happen with the RACB share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
Underwriters
Jefferies
CO-Managers